Carboxylesterase 1 (CES1) Peptide
Quick Overview for Carboxylesterase 1 (CES1) Peptide (ABIN936783)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- ANFARNGNPN GEGLPHWPEY NQKEGYLQIG ANTQAAQKLK DKEVAFWTNL
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CES1 antibody,
Alternative Names: Carboxylesterase 1 control peptide, Carboxylesterase 1 antibody Blocking Peptide, Anti-Carboxylesterase 1 Blocking Peptide, CES1 Blocking Peptide, Monocyte/Macrophage Serine Esterase 1 Blocking Peptide, CEH Blocking Peptide, CES2 Blocking Peptide, HMSE Blocking Peptide, HMSE1 Blocking Peptide, SES1 Blocking Peptide, Carboxylesterase 1, Carboxylesterase -1, Carboxylesterase 1, Carboxylesterase -1 Blocking Peptide, Carboxylesterase 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- CES1 (Carboxylesterase 1 (CES1))
-
Background
- CES1 is one of the enzymes responsible for the hydrolysis of ester- and amide-bond-containing drugs such as cocaine and heroin. They also hydrolize long-chain fatty acid esters and thioesters. This enzyme is known to hydrolyze aromatic and aliphatic esters and is necessary for cellular cholesterol esterification. It may also play a role in detoxification in the lung and/or protection of the central nervous system from ester or amide compounds. Carboxylesterase deficiency may be associated with non-Hodgkin lymphoma or B-cell lymphocytic leukemia.
-
Molecular Weight
- 62 kDa
Target
-